Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Francois Vaillant, Delphine Merino, Lily Lee, Kelsey Breslin, Bhupinder Pal, Matthew E Ritchie, Gordon K Smyth, Michael Christie, Louisa J Phillipson, Christopher J Burns, G Bruce Mann, Jane E Visvader, Geoffrey J Lindeman
Cancer Cell | CELL PRESS | Published : 2013
Awarded by National Health and Medical Research Council, Australia (NHMRC)
This work was supported by the National Health and Medical Research Council, Australia (NHMRC: 461221 and 1016701); NHMRC IRIISS; the Victorian State Government through Victorian Cancer Agency funding of the Victorian Breast Cancer Research Consortium and Operational Infrastructure Support; the Australian Cancer Research Foundation; The National Breast Cancer Foundation (NBCF); and the Qualtrough Family Bequest. J.E.V. was supported by a NHMRC Australia Fellowship, G.K.S. and G.J.L. by NHMRC Research Fellowships, and D.M. by a NBCF Early Career Fellowship.